Location History:
- Avuilly, CH (1979)
- Avully, CH (1981 - 1987)
- Grand-Saconnex, CH (1985 - 1989)
Company Filing History:
Years Active: 1979-1989
Title: **Alban I Albert: Innovator in Vascular Disease Treatments**
Introduction
Alban I Albert is a noted inventor based in Grand-Saconnex, Switzerland, recognized for his significant contributions to pharmaceutical innovations. With a total of seven patents to his name, Alban has focused his research on compounds that exhibit valuable pharmacological properties, particularly in the treatment of vascular diseases.
Latest Patents
Among Alban's latest patents is a groundbreaking development related to benzopyrans and their application in treating vascular diseases. One patent highlights isoflavans of a specific formula, demonstrating their potential as valuable therapeutic agents. These compounds are produced using established methods, marking a significant advancement in pharmaceutical preparations. Additionally, he has developed pharmaceutical preparations containing (+)-cyanidan-3-ol derivatives, which have shown effectiveness in treating liver and venous diseases. These creations include various compounds and their therapeutically applicable salts, expanding the possibilities for effective treatment options in modern medicine.
Career Highlights
Alban I Albert's professional journey includes pivotal roles in notable companies like Zyma SA and Ciba-Geigy Corporation, where he applied his expertise in drug development and innovation. His work has not only contributed to the companies he has been part of but also significantly impacted the pharmaceutical industry.
Collaborations
Throughout his career, Alban has collaborated with esteemed professionals such as Pierre Courbat and Andre J. Weith. These partnerships have undoubtedly facilitated the exchange of innovative ideas and paved the way for advancements in the pharmaceutical domain, showcasing the strength of collaboration in driving research forward.
Conclusion
Alban I Albert stands out as an inventor with a dedicated focus on innovations that address critical health issues. His patents reflect his commitment to advancing treatments for vascular and liver diseases, as well as promoting ongoing research collaborations that are vital for medical advancements. As the healthcare industry continually evolves, Alban's work remains pivotal in shaping effective therapeutic solutions.